Publication | Open Access

The efficacy and safety of tofacitinib in Asian patients with moderate to severe chronic plaque psoriasis: A Phase 3, randomized, double-blind, placebo-controlled study

Clinical TrialsClinical DermatologyChronic Plaque PsoriasisSkin PharmacologyPharmacotherapyDermatologyAsian PatientsMedicinePhase 3